An epidemiological study of the effects of statin use on airflow limitation in patients with chronic obstructive pulmonary disease.

Background And Objective: Chronic obstructive pulmonary disease (COPD) is considered to be a systemic inflammatory disease, and systemic inflammation has been noted as a factor contributing to cardiovascular disease, which is one of the comorbidities associated with COPD. On the other hand, pleiotropic effects, such as the anti-inflammatory effects of statins, have attracted attention in recent years, and there have been a variety of reports regarding the usefulness of statins for patients with COPD.

Methods: We investigated whether the use or non-use of statins influenced the prevalence of airflow limitation.